AZTA · Azenta, Inc.
$30.73
+1.82% last session
End-of-day data · close of 2026-09-11
Market cap
$1B
Enterprise value
$1B
Trailing P/E
—
Forward P/E
51.4
Dividend yield
—
Beta
1.39
Avg volume
1M
Employees
3K
Daily Change %
1.82%
5 Days Change
-3.77%
10 Days Change
-7.66%
30 Days Change
-9.70%
60 Days Change
18.89%
Month to Day Change
-4.50%
Year to Day Change
-9.35%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — AZTA
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-08-06
Latest call per bank · past 12 months
Jefferies
Buy$40.00
+32.5% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-06 | Evercore ISI Group | Maintains | Outperform | $28.00 → $35.00 |
| 2026-08-05 | Needham | Maintains | Buy | $33.00 → $37.00 |
| 2026-05-06 | Needham | Maintains | Buy | $44.00 → $33.00 |
| 2026-04-06 | Evercore ISI Group | Maintains | Outperform | $45.00 → $35.00 |
| 2026-03-17 | Needham | Reiterates | Buy | $44.00 |
| 2026-02-05 | Evercore ISI Group | Maintains | Outperform | $50.00 → $45.00 |
| 2026-02-04 | Jefferies | Maintains | Buy | $42.00 → $40.00 |
| 2026-02-04 | Needham | Reiterates | Buy | $44.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-09-11
- RSI (14): RSI is 46 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 2.1% above the 50-day MA ($30.11).
- Price vs 200-day MA: Trading 8.6% above the 200-day MA ($28.30).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is negative (-0.58) — short-term momentum is fading.
- 52-week range: Price sits between the 52-week low ($16.02) and high ($41.01).
AZTA Price Chart
Loading chart for AZTA…
Fundamentals
About Azenta, Inc.
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, gene synthesis, and related services. The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
More in Medical Instruments & Supplies
ISRG
Intuitive Surgical, Inc.
$129B -37.6% YTD
BDX
Becton, Dickinson and Company
$48B 20.1% YTD
MDLN
Medline Inc.
$44B -18.9% YTD
ALC
Alcon Inc.
$32B -12.8% YTD
RMD
ResMed Inc.
$32B -7.9% YTD
WST
West Pharmaceutical Services, I
$24B 22.8% YTD
SOLV
Solventum Corporation
$15B 13.6% YTD
BAX
Baxter International Inc.
$13B 27.8% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.